The Clinical Drug Ebselen Attenuates Inflammation and Promotes Microbiome Recovery in Mice after Antibiotic Treatment for CDI

Clostridium difficile infection (CDI) is an enteric bacterial disease that is increasing in prevalence worldwide. C. difficile capitalizes on gut inflammation and microbiome dysbiosis to establish infection, with symptoms ranging from watery diarrhea to toxic megacolon. We reported that the safe-in-...

Descripción completa

Detalles Bibliográficos
Autores principales: Garland, Megan, Hryckowian, Andrew J., Tholen, Martina, Oresic Bender, Kristina, Van Treuren, William W., Loscher, Sebastian, Sonnenburg, Justin L., Bogyo, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263476/
https://www.ncbi.nlm.nih.gov/pubmed/32483557
http://dx.doi.org/10.1016/j.xcrm.2020.100005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263476/
https://www.ncbi.nlm.nih.gov/pubmed/32483557
http://dx.doi.org/10.1016/j.xcrm.2020.100005

Ejemplares similares